Reported Jun 24, 2026 · Ongoing
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made…
Ajanta Pharma USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Ajanta Pharma USA Inc · 400 Crossing Blvd Ste 102 · Bridgewater, NJ · 08807-2863
Is this the product you have?
- Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets
- Marketed byAjanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03
- Lot codes and dates
- LotPA00805
- expires01/31/2029
- Amount recalled
- 6,143 bottles
Where it was sold
- Nationwide
Why it was recalled
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Ajanta Pharma USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.